Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration

Ida Herdlevaer1,2, Torbjørn Kråkenes1, Manja Schubert2

  • 1Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Abstract

Insights

Anti-Yo antibodies target CDR2L in the cytoplasm of Purkinje neurons, potentially disrupting protein synthesis in paraneoplastic cerebellar degeneration (PCD). CDR2 localizes to the nucleus, interacting with splicing factors.

Area of Science:

  • Neuroimmunology
  • Molecular Neuroscience
  • Cell Biology

Background:

  • Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies is a severe autoimmune neurological disorder.
  • Cerebellar degeneration-related proteins CDR2L and CDR2 are implicated in anti-Yo PCD pathogenesis.
  • Understanding the precise roles and interactions of CDR2L and CDR2 is crucial for elucidating PCD mechanisms.

Purpose of the Study:

  • To determine the subcellular localization of CDR2L and CDR2.
  • To identify binding partners of CDR2L and CDR2.
  • To investigate the functional consequences of anti-Yo antibody binding to these proteins in PCD.

Main Methods:

  • Mass spectrometry-based proteomics to confirm antibody specificity and identify binding partners.
  • Super-resolution microscopy and proximity ligation assay for subcellular localization studies.
  • Co-immunoprecipitation to validate protein-protein interactions.

Main Results:

  • Yo antibodies specifically recognize CDR2L, which is localized to the cytoplasm.
  • CDR2L was found to co-localize with the 40S ribosomal protein S6.
  • CDR2 was localized to the nucleus and co-localized with nuclear speckle proteins SON, EIF4A3, and Srsf2.

Conclusions:

  • Anti-Yo antibodies binding to CDR2L in Purkinje neurons may disrupt ribosomal function and protein synthesis, contributing to PCD.
  • The interaction of CDR2L with ribosomal proteins and CDR2 with nuclear speckle proteins provides insights into PCD pathogenesis.